Songjiang Ma
President at Gyre Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Gyre Therapeutics Inc., 2 years.
Gyre Therapeutics Inc.
Director · President
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 28, 2025 | Gyre Therapeutics Inc. | Open-market sale | −558 | $10.07 | $5,619 |
| May 27, 2025 | Gyre Therapeutics Inc. | Open-market sale | −2,000 | $10.28 | $20,560 |
| May 23, 2025 | Gyre Therapeutics Inc. | Open-market sale | −182 | $10.24 | $1,864 |
| May 22, 2025 | Gyre Therapeutics Inc. | Open-market sale | −2,000 | $10.97 | $21,940 |
| May 21, 2025 | Gyre Therapeutics Inc. | Open-market sale | −2,000 | $10.83 | $21,660 |
| May 20, 2025 | Gyre Therapeutics Inc. | Open-market sale | −2,000 | $11.25 | $22,500 |
| May 19, 2025 | Gyre Therapeutics Inc. | Open-market sale | −2,000 | $11.11 | $22,220 |
| May 16, 2025 | Gyre Therapeutics Inc. | Open-market sale | −2,000 | $11.31 | $22,620 |
| May 15, 2025 | Gyre Therapeutics Inc. | Open-market sale | −2,000 | $10.68 | $21,360 |
| May 14, 2025 | Gyre Therapeutics Inc. | Open-market sale | −20 | $11.30 | $226 |
| May 13, 2025 | Gyre Therapeutics Inc. | Open-market sale | −2,000 | $11.37 | $22,740 |
| May 12, 2025 | Gyre Therapeutics Inc. | Open-market sale | −2,000 | $10.56 | $21,120 |
| Mar 21, 2025 | Gyre Therapeutics Inc. | Open-market sale | −174 | $10.00 | $1,740 |
| Mar 20, 2025 | Gyre Therapeutics Inc. | Open-market sale | −2,000 | $10.09 | $20,180 |
| Mar 19, 2025 | Gyre Therapeutics Inc. | Open-market sale | −2,000 | $10.13 | $20,260 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.